Business
CollPlant To Present at the H.C. Wainwright Annual Global Investment Conference in September
REHOVOT, Israel, Sept. 7, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and
About this update from Collplant Biotechnologies Ltd.
[{"type":"text","content":"REHOVOT, Israel, Sept. 7, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced that Mr. Yehiel Tal, Chief Executive Officer of CollPlant, will provide an overview of the company at the H.C. Wainwright 23rd Annual Global Investment Conference which will be held virtually on September 13-15, 2021.\nThe presentation will be available on-demand through the H.C. Wainwright conference portal, starting at 7 a.m. EST, on Monday, September 13, 2021.\nRegistration Link: click here.\nAbout CollPlant\nCollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics. The Company's products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing, and are ushering in a new era in regenerative and aesthetic medicine. \nCollPlant recently entered a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market. Later in 2021, CollPlant entered a strategic co-development agreement with 3D Systems for a 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures in combination with an implant.\nFor more information, visit http://www.collplant.com.\nSafe Harbor Statements\nThis press release may include forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to CollPlant's objectives plans and strategies, as well as statements, other than historical facts, that address activities, events or developments that CollPlant intends, expects, projects, believes or anticipates will or may occur in the future. These statements are often characterized by terminology such as \"believes,\" \"hopes,\" \"may,\" \"anticipates,\" \"should,\" \"intends,\" \"plans,\" \"will,\" \"expects,\" \"estimates,\" \"projects,\" \"positioned,\" \"strategy\" and similar expressions and are based on assumptions and assessments made in light of management's experience and perception of h...